{"cluster": 42, "subcluster": 4, "abstract_summ": " The emergence of the novel human coronavirus SARS-CoV-2 in Wuhan, China has caused a worldwide epidemic of respiratory disease (COVID-19) Vaccines and targeted therapeutics for treatment of this disease are currently lacking . Here we report a human monoclonal antibody that neutralizes SARS . This cross-neutralizing antibody targets a communal epitope on these viruses and offers potential for prevention and treatment ."}